A new immunoassay developed by PerkinElmer has been demonstrated to successfully screen for Duchenne muscular dystrophy (DMD) – a fatal X-chromosome recessive disorder, affecting 1 in 5000 male births world-wide.

The endothelial cells that line our blood vessels play an important role in maintaining and regulating blood flow, contributing to the natural process called haemostasis. PerkinElmer Opera Phenix™ system highlighted.

PerkinElmer, Inc. has announced the launch of the NexION® 2000 Inductively Coupled Plasma Mass Spectrometer (ICP-MS). This innovative new system is specifically designed to handle any sample matrix, address any interference, and detect any particle size.

PerkinElmer Inc. (PKI) reported third-quarter profit of $58.1 million. The Waltham, Massachusetts-based company said it had net income of 53 cents per share. Earnings, adjusted for one-time gains and costs, were 68 cents per share.

Severe combined immunodeficiency (SCID, or “bubble-boy disease”) is an inherited genetic condition resulting from a severe defect in the immune system that makes it difficult or impossible for the affected individual to fight off infections.

Many of the foods and drinks we consume every day are not as safe as we think. Despite increasingly stringent safety regulations, food fraud, adulterated products, and ingredients containing harmful chemicals or pathogens continue to slip through the global safety net to sicken an estimated 600 million people every year.

PerkinElmer, Inc (USA) have announced the launch of the Avio 200 Inductively Coupled Plasma Optical Emission Spectrometer (ICP-OES), the industry’s most compact system designed for efficient multi-elemental inorganic analysis.

Customer Care

Connect

NOTICE: You are now leaving the PerkinElmer website. The privacy policy of the site to which you are going may differ from PerkinElmer's privacy policy. To remain at the PerkinElmer site and return to your previous page, click the button Cancel. To leave the PerkinElmer site for the link you selected, click the button OK.